Alterazioni Ormonali Dell'insufficienza Renale Cronica

Maxwell A.P. , Lappin T.R.J. , Johnson C.F. , Bridges J.M. , McGeown M. Erythropoietin production in kidney tubular cells. Br J Ematol 1990; 74: 535–9.

Caro J. , Brown S. , Miller O. , Murray T.G. , Erslev A.J. Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 1979; 93: 449.

Chandra M. , Miller M.E. , Garcia J.F. , Mossey R.T. , McVicar M. Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients. Nephron 1985; 39: 26.

McGonigle R.J.S. , Wallin J.D. , Shaddusk R.K. , Fisher J.W. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int 1984; 25: 37.

Brunette M.G. , Chan M. , Fernere C. , Roberts K.D. Site of 1.25-(OH)₂D3 synthesis in the kidney. Nature 1978; 276–87.

Shany S. , Rappoport J. , Zuili I. , Yankowitz N. , Chaimovitz C. Enhancement of 24,25-dihydroxyvitamin D levels in patients treated with continuous ambulatory peritoneal dialysis. Nephron 1986; 42: 141.

Coburn J.W. , Massry S.G. lises and actions of 1.25-dihydroxyvitamin D3 in uremics. Contr Nephrol 1980; 18: 1.

Battle D.C. , von Riotte A. , Lang G. Delayed hypotensive response to dialysis in hypertensive patients with end stage renal disease. Am J Nephrol 1986; 6: 14.

Naik R.B. , Mathias C.J. , Reid J.L. , Warren D.J. Effect of hemodialysis on the control of the circulation in patients with chronic renal failure. Am J Nephrol 1985; 5: 96.

Grzeszczak W. , Kokot F. , Dulawa J. Influence of naloxone on prolactin secretion in patients with acute and chronic renal failure. Clin Nephrol 1984; 21: 47.

Bauer A.G.C. , Wilson J.H.P. , Lamberts S.W.J. The kidney is the main site of prolactin elimination in patients with liver disease. J Clin Endocrinol Metab 1980; 51: 70.

Czekelskj S. Hormonal abnormalities in chronic uremia current nephrological problem. Pol Arch Med Wewn 1979; 61: 349.

Preces R. , Horkajada C. , Lopez-Novoa J.M. , Frutos M.A. , Casado S. , Hernando L. Hyperprolactinemia in chronic renal failure. Impaired responsiveness to stimulation and suppression. Normalization after transplantation. Nephron 1981; 28: 11.

Kokot F. Endocrine changes in chronic renal insufficiency. Z Gesamte Inn Med 1979; 34: 743.

McDonald W.J. , Golper T.A. , Mass R.D. Adrenocorticotropin-cortisol axis abnormalities in hemodialysis patients. J Clin Endocrinol Metab 1979; 48: 92.

Kolbe K. Investigation of Cortisol production in patients with terminal renal failure undergoing hemodialysis treatment. Dissertation, Aachen 1979.

Giordano C. , De Santo N.G. , Carella C. Thyroid status and neprhon loss - a study in patient with chronic renal failure, end stage renal disease and/or hemodialysis. Int J Artif Organs 1984; 7: 119.

Kapstein E.M. , Feinstein E.J. , Nicoloff J.T. , Massry S.G. Serum reverse T3 and T4 kinetics in patients with chronic renal failure. J Clin Endocrinol Metab 1983; 57: 181.

Sennesal J.J. , Verbeelen D.L. , Jonckeer M.H. Thyroid disfunction in patients on regular hemodialysis: evaluation of the stable intrathyroidal iodine pool, incidence of goiter and free thyroid hormone concentratrion. Nephron 1985; 41: 141.

Czekalsky S. , Malczewska B. Serum cencentration of pituitary, thyroid and gonadal hormone in non dialyzed and dialyzed males with chronic renal failure. Proc Eur Dial Transplant Assoc 1978; 15: 559.

Lim V.S. , Henriguez C. , Sievertsen G. , Frohman L.A. Ovarian function in chronic renal failure: evidence suggesting hypotalamic anovulation. Ann Intern Med 1980; 93: 21.

Freitag J. , Marlin K.J. , Hruska K.A. Impaired parathyroid hormone metabolism in patients with chronic renalfailure. N Engl J Med 1978; 298: 29.

Massry S.G. Current status of the role of parathyroid hormone in uremic toxicity. Contrib Nephrol 1985; 49: 1.

Weidmann P. , Maxwell M.H. , Delima J. Control of aldosterone responsiveness in terminal renal failure. Kidney Int 1975; 7: 351.

DeFrozo R.A. , Andres R. , Edgar P. , Walker W.J. Carbohydrate metabolism in uremia. A review. Medicine 1973; 52: 469.

Brech W.J. Uremic glucose intolerance-diabetes mellitus. In: Franz H.E. ed. Blood Purification Treatment-technical and clinical aspects Stuttgart: Hrsg Thiene, 1981; 167.

Devidson M.B. , Fister M.B. Effect of protein intake and dialysis on the abnormal growth hormone, glucose and insulin homeostasis in uremia. Metabolism 1976; 25: 455.

Sherwin R.S. , Basti C. , Finkelstein F.O. Influence of uremia and hemodialysis on the turn over and metabolic effect of glucagon. J Clin Invest 1976; 57: 722.

El Ghonaimy E. , Barsoum R. , Soliman M. Serum gastrin in chronic renal failure: morphological and physiological correlations. Nephron 1985; 39: 86.